NGM Clinical Study Site

Los Angeles, California 90095

1 studies enrolling now · 6 studies all time

What they study most

Bladder Cancer, Bladder Urothelial Cancer, Breast Cancer, CRC (Colorectal Cancer), Cancer Cachexia, Cervical Cancer, Cholangiocarcinoma, Colorectal Cancer, Colorectal Carcinoma, Compensated Cirrhosis, Endocervical Cancer, Esophageal Cancer

Studies at this site

• An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorectal Cancer Who Have Cancer Cachexia. — Recruiting now
• Evaluation of Efficacy, Safety and Tolerability of Aldafermin in a Phase 2b, Randomized, Double-blind, Placebo-controlled, Multi-center Study In Subjects With Nonalcoholic Steatohepatitis and Stage 2/3 Fibrosis (ALPINE 2/3) — Completed
• Study of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination Therapy — Completed
• Study of Aldafermin (NGM282) in Subjects With Compensated Cirrhosis (ALPINE 4) — Completed
• Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors — Running, not enrolling
• Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies — Status unconfirmed